Scientific publications

SUDOSCAN in wild-type cardiac amyloidosis and AA amyloidosis – JFMA 2020

Cardiac neuropathy, Events / By

Multidisciplinary French speaking day of Amyloidosis – JFMA 2020 Last month, SUDOSCAN was presented at the virtual Multidisciplinary French speaking day of Amyloidosis. The congress gathered 300 participants with a large scientific program on the different amyloidosis types. Amyloidosis is an acquired or hereditary rare disease due to amyloid protein deposits into organs. Several types …

SUDOSCAN in wild-type cardiac amyloidosis and AA amyloidosis – JFMA 2020 Read More »

SUDOSCAN in asymptomatic Hepatitis C

Infectious disease, Scientific publications / By

SUDOSCAN detects small fiber neuropathy in asymptomatic hepatitis C virus-related cirrhosis patients ES. Tharwa et al.Article title: Sudomotor Changes in Hepatitis C Virus Infection with or without Diabetes Mellitus: A Pilot Study in Egyptian Patients. Am. J. Trop. Med. Hyg., 00(0), 2020, pp. 1–5. In a study conducted by Tharwa et al from Menoufia University, Egypt, …

SUDOSCAN in asymptomatic Hepatitis C Read More »

SUDOSCAN utility to detect foot sudomotor dysfunction in type 1 diabetes without clinical evidence of peripheral neuropathy

Diabetes, Scientific publications / By

SUDOSCAN UTILITY TO DETECT FOOT SUDOMOTOR DYSFUNCTION IN TYPE 1 DIABETES WITHOUT CLINICAL EVIDENCE OF PERIPHERAL NEUROPATHY Danyelle Lorrane Carneiro Veloso, Raira Castilho Gomes Nascimento, Eliziane Brandao Leite, Luisiane de Avila Santana, Angelica Amorim Amato. Article title: Predictors of sudomotor dysfunction in patients with type 1 diabetes without clinical evidence of peripheral neuropathy. Diabetes Research and …

SUDOSCAN utility to detect foot sudomotor dysfunction in type 1 diabetes without clinical evidence of peripheral neuropathy Read More »

Clinical impact of dpp-4 inhibitor on autonomic neuropathy followed up by SUDOSCAN

Diabetes, Scientific publications / By

CLINICAL IMPACT OF DPP-4 INHIBITOR ON AUTONOMIC NEUROPATHY FOLLOWED UP BY SUDOSCAN​ A. Syngle, S. Chahal, K. Vohra. Article title: Efficacy and tolerability of DPP4 inhibitor, teneligliptin, on autonomic and peripheral neuropathy in type 2 diabetes: an open label, pilot study. Neurological Sciences. 2020 Aug 15. A new publication by Syngle et al. in Neurological …

Clinical impact of dpp-4 inhibitor on autonomic neuropathy followed up by SUDOSCAN Read More »

Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

To receive our latest scientific news:

Website dedicated
to health professionals

I am a health professional

Scroll to Top